Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal cannabidiol for chronic temporomandibular joint pain
RBR-4yp5qgzCompleted
- Sponsor
- Gláucia Colli
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of cannabidiol in temporomandibular disorder (TMD) (2 arms), sponsored by Gláucia Colli. Started Oct 2025; status: completed.
02
Drugs
cannabidiol
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on RBR-4yp5qgz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4yp5qgz.